CLNN
NASDAQ
$5.73
Clene Inc (CLNN)
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of new clean-surface nanotechnology (CSN) therapies. The company is headquartered in Salt Lake City, Utah.
Sector:
Consumer Defensive
Industry:
Packaged Foods
Target: $32.20 (+461.95%)
Market Cap
$71M
Free Cash Flow Yield
-25.53%
Beta (5Y)
1.01
Price Chart
Valuation
Market Cap$71M
P/S574.07
P/B7.83
Profitability
Total Revenue (TTM)$134K
Gross Profit (TTM)$111K
EBITDA-$20M
Operating Margin-13740%
EPS-$3.18
Financial Health
Debt-to-Equity-94.1%
Free Cash Flow Yield-25.53%
Growth & Risk
Revenue 5Y CAGR-17.42%
FCF 5Y CAGR-6.55%
Beta (5Y)1.01
Sharpe Ratio0.85